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Maternal smoking during pregnancy is a significant risk factor of renal pathology in the offspring. E-
cigarettes are perceived to be a safe option and are increasingly used by pregnant women either 
continuously during pregnancy or as a replacement for tobacco cigarettes. This study aimed to 
determine the effects of replacing tobacco cigarettes with e-cigarettes during pregnancy, and 
continuous e-cigarette use during pregnancy on the offspring’s kidney. Female Balb/c mice were 
exposed to either air (Sham) or tobacco cigarette smoke (SE) for 6 weeks prior to mating, during 
gestation and lactation. A subset of the SE group received e-cigarette vapour (containing nicotine) 
after mating until pups weaned. Additional female mice were continuously exposed to e-vapour 
(either with or without nicotine) for 6 weeks prior to mating until pups weaned. Kidneys and urine 
from the male offspring were assessed at postnatal day 1, day 20 (weaning), and 13 weeks of age 
(adulthood). E-cigarette replacement was less detrimental to renal development and functional 
outcomes than continuous SE exposure during pregnancy. However, continuous e-vapour exposure 
during pregnancy increased markers of oxidative stress, inflammation and fibrosis in the adult 
offspring, independent of nicotine. E-cigarette use during pregnancy confers future risk to the 
offspring’s kidney. 
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Introduction 
Cigarette smoking is a risk factor for the development of end stage kidney disease, with nicotine being 
considered a major contributor as it accumulates within the kidneys and is secreted through the 
glomeruli and renal tubules 1. Maternal smoking during pregnancy confers similar risks to the 
offspring 1-3. A recent study in children demonstrated an association between maternal smoking 
during pregnancy and the presence of proteinuria in 3-year old offspring 4, indicating impaired kidney 
function in early childhood and an increased risk of chronic kidney disease later in life. Maternal 
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smoking restricts intrauterine growth, leading to reduced birth weight and the underdevelopment of 
multiple organs, including the kidneys 5-7. Furthermore, many toxins present in cigarette smoke, such 
as nicotine, can pass the blood-placenta barrier, directly harming foetal organs. Thus, maternal 
smoking during pregnancy can affect the kidney health of the unborn child 2. Previously, we have 
comprehensively studied the detrimental impacts of prenatal cigarette smoke exposure (SE) on the 
offspring and discovered that oxidative stress and mitochondrial dysfunction play critical roles in 
delayed early renal development and renal damage due to maternal SE 6-9. In addition, oxidative stress 
injury markers, including nitrotyrosine and 8-hydroxydeoxyguanosin (8-OHdG), were also increased 
in the kidneys from the SE offspring in line with increased mitochondrial oxidative stress level 7-9. 
 
Nicotine addiction contributes to the failure of smoking cessation especially during pregnancy 10, 11, 
leading to the pursuit of alternative forms of nicotine administration. E-cigarettes are one such 
nicotine delivery system and their usage has steadily increased since 2008, especially amongst the 
younger population 12, with 20% of American middle and high-school students vaping nicotine in 
2018 13. E-cigarettes are perceived as a safe and effective replacement to tobacco cigarettes, leading 
to increased usage among pregnant women who feel stigmatised by their tobacco smoking habits 14-
16. Even among obstetricians in 2012, 13.5% believe that e-cigarette vaping during pregnancy poses 
no adverse health risks to either the user or the unborn child 17. Thus, e-cigarettes have become the 
nicotine replacement therapy of choice among pregnant women, being favoured over nicotine patches 
18. Between 2014 and 2016, ever use of e-cigarettes during pregnancy ranged from 13% to 15%, with 
dual usage (8.54%) being more popular than e-cigarette only vaping (6.52%) and cigarette only 
smoking (5.62%) 16, 18, 19.  
 
Although e-cigarettes are considered safer than tobacco cigarettes due to less harmful chemicals 
generated, they have not been established as a completely safe alternative. E-cigarettes heat a liquid 
(often containing propylene glycol, glycerol, nicotine and flavouring additives), producing many 
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toxic by-products in the process 20. We have previously shown increased inflammatory responses in 
offspring’s lungs and brains in response to continuous maternal e-vapour exposure 21-23. Interestingly, 
maternal exposure to nicotine-containing and nicotine-free e-vapour differentially altered 
inflammatory markers, suggesting that nicotine is not solely responsible for the harmful effects to the 
developing foetus 21. Furthermore, another study showed that chronic e-vapour exposure in mice 
impaired glomerular filtration rate and increased kidney fibrosis 24. However, the impact of maternal 
e-vapour exposure on the renal health outcome in the offspring is unknown. Similarly, it is unknown 
whether using e-vapour to replace tobacco smoke (replacement) from conception can protect the 
offspring’s renal health. Therefore, the aims of this study were to determine the effects of, i) replacing 
tobacco smoke with nicotine containing e-vapour during pregnancy and lactation, and; ii) continuous 
e-vapour (nicotine containing and nicotine-free) exposure during pregnancy and lactation on renal 
development and markers of oxidative stress, inflammation and fibrosis in adult kidneys in the 
offspring. Male offspring were studied because they are more susceptible to kidney damage induced 
by maternal smoking while female offspring are protected, as elucidated in our previous studies 6, 25. 
Materials and Methods  
Animals  
The animal experiments were approved by the Animal Care and Ethics Committee of the University 
of Technology Sydney (ACEC#2014-638 and ETH15-0025) and performed according to the 
Australian National Health & Medical Research Council Guide for the Care and Use of Laboratory 
Animals. Female Balb/C mice (7 weeks old, Animal Resource Centre, WA, Australia) had ad libitum 
access to standard laboratory chow and water while housed at 20±2 °C and maintained on a 12-h light, 
12-h dark cycle (lights on at 06:00 h). Female mice were acclimatised for a week prior to the exposure 
treatments detailed below.  
 
Modelling maternal smoking and e-cigarette replacement  
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Female mice were either exposed to room air (Sham) or tobacco smoke (SE) generated by 2 cigarettes 
(Winfield Red, ≤16 mg tar, ≤1.2 mg nicotine, and ≤15 mg of CO; VIC, Australia) twice daily, 6 
weeks before mating and throughout gestation and lactation. This was adopted from our protocol of 
maternal SE 6, 7, 25, and results in nicotine exposure in the offspring which is equivalent to human 
babies from light smokers 26.  In a subset of the SE exposed mice, SE exposure was replaced with e-
vapour generated from e-liquid containing 18mg/mL nicotine (Replacement) from mating until the 
pups weaned (Figure 1), as previously described 21, 23. This nicotine exposure was equivalent to that 
of 2 tobacco cigarettes as indicated by similar serum cotinine (the major, stable nicotine metabolite) 
levels in the offspring, as we have previously published in the same cohort of offspring 21.  
 
Modelling maternal e-cigarette vaping  
To investigate the impact of continuous e-vapour exposure, another 2 groups of female mice were 
exposed to either e-vapour generated from e-liquid containing 18mg/mL nicotine (E-cig18), or e-
vapour from nicotine free e-liquid (E-cig0) for 6 weeks prior to mating and throughout gestation and 
lactation (Figure 1). Aerosols were generated by a human-use e-cigarette device (KangerTech 
NEBOX, 30 Watts, 0.5 Ohms, KangerTech, Shenzen, China) from commercial e-liquids (50% 
propylene glycol/50% vegetable glycerine, tobacco flavour additives, Vaper Empire, VIC, Australia). 
Mice were exposed twice daily (10am, 3pm) for 2 x 15 minute (4 x 5 second puffs with 20 second 
interval between each puff, 60mL), with a 5-minute washout interval. 
Dams were removed from their home cages during exposure, while the male breeders and pups were 
not exposed. Pups were weaned at postnatal day (P) 20 and maintained without additional intervention. 
Male offspring were euthanized after deep anaesthesia (2% isoflurane) at P1, P20, and 13 weeks 
(W13). The animals analysed in this study were a sub-cohort of a previously published study 21. 
Kidneys from the male offspring were harvested, weighed and then either snap frozen and stored at -
80°C or fixed in 10% formalin for further analyses. Kidney weights (%) were calculated as a fraction 
of body weight.  
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Urine from the W13 male offspring was collected from the bladder via puncture and used for albumin 
and creatinine measurements using Murine Microalbuminuria ELISA kit (Albuwell M) and 
Creatinine Companion kit (Exocell Inc, PA, USA), respectively as per manufacturer’s instructions.   
 
Real-time PCR 
Macrophage chemoattractant protein (MCP)-1, NADPH oxidase 4 (Nox4), TNF-α and IL-6 
expression were measured in the W13 offspring. These are commonly used markers of kidney 
inflammation, a key contributor to the development of renal fibrosis and chronic kidney disease. Total 
mRNA was extracted from the kidneys using TriZol reagent (Thermo Fisher Scientific, MA, USA) 
and first-strand cDNA generated according to manufacturer’s specifications (Promega, Madison, WI, 
USA). The expression of MCP-1 (forward primer: 5’-GTTGTTCACAGTTGCTGCCT-3’, and 
reverse primer: 5’-CTCTGTCATACTGGTCACTTCTAC-3’) and Nox4 (forward primer: 
5’CTGGTCTGACGGGTGTCTGCATGGTG-3’, and reverse primer: 5’-
CTCCGCACAATAAAGGCACAAAGGTCCAG-3’) were measured using primers labelled by 
SYBR green® (Sigma-Aldrich, MO, USA) as we have published previously 9, 27. TNF-α 
(CCCTCACACTCAGATCATCTTCTCA, NCBI reference: NM_013693.2, ID: Mm00443259_g1, 
Thermo Fisher Scientific, MA, USA) and IL-6 (ATGAGAAAAGAGTTGTGCAATGGCA, NCBI 
reference: NM_031168.1, ID: Mm00446190_m1, Thermo Fisher Scientific, MA, USA) expression 
were measured using pre-optimised and validated TaqMan® primers and probes. Values are 
expressed as fold changes to the Sham group and 18S rRNA expression was used as the house-
keeping gene. 
 
Glomerular density and perimeter 
Formalin fixed, paraffin embedded kidneys were sectioned at 5µm and stained with Periodic Acid-
Schiff (PAS). The number of developed glomeruli in a given area was manually counted in the whole 
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kidney for P1 and from 5 non-overlapping areas on the same slide and averaged for P20 and W13 
offspring. Three non-consecutive slides were used for each animal, as previously described 6. The 
glomerular perimeter (10/slide) was measured using ImageJ (National Institutes of Health, MD, USA).  
Renal histology and morphometric analysis 
  
Glomerulosclerosis and tubulointerstitial fibrosis were assessed using PAS and Picrosirius red 
staining (PSR). The whole kidney cortex was examined under 400x magnification using a light 
microscope (Olympus photomicroscope linked to a DFC 480 digital camera). Two independent 
assessors reviewed histological sections in a blinded manner and scored glomerulosclerosis. The 
characteristic features of tubulointerstitial fibrosis include tubular atrophy or dilatation, presence of 
mononuclear inflammatory cells, widening of interstitial spaces with deposition of ECM, interstitial 
cell proliferation and wrinkling or thickened tubular basement membrane were also reviewed. PSR 
staining was performed as we have previously demonstrated and quantitated 28. Ten non-overlapping 
fields in each animal (5 animals/group) were assessed in total. The average staining area was 
represented.  
Glomerulosclerosis was graded as follows: 0 - normal, 1 - < 25% involvement, 2 < 50% involvement, 
3 - < 75%, and 4 - > 75% sclerosis. A semi-quantitative glomerulosclerosis index  score was 
calculated from averaging scores from all counted glomeruli in one section.  
Mitochondrial density and ROS level 
Frozen kidneys were sectioned to quantify mitochondrial density and ROS levels. Kidney 
mitochondria were visualised using MitoTracker Green (Thermo Fisher Scientific, Australia) and 
images were acquired at 488 nm excitation wavelength and detected in the 510-550nm emission range 
as previously reported 9. For total reactive oxygen species (ROS), CellROX Deep Red (Thermo Fisher 
Scientific, Australia) was used and images were acquired at 633 nm excitation wavelength and 
detected in the 640-680 nm emission range. All imaging parameters including laser intensities, 
photomultiplier tubes voltage and pinholes were kept constant during imaging. The MitoTracker and 
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CellRox images were overlayed and the correlation coefficient was calculated to provide information 
on mitochondrial specific ROS, as we have previously reported 8. Data was generated using ImageJ 
(National Institutes of Health, MD, USA).  
Immunohistochemistry 
Formalin fixed, paraffin embedded kidneys were sectioned at 5µm. Sections were deparaffinised and 
treated with xylene and decreasing grades of ethanol to distilled water. For antigen retrieval, sections 
were heated and pressurised in either citrate buffer (pH 6.0) or EDTA buffer (pH 8.0) and then cooled 
in a water bath. Sections were incubated with the following anti-rabbit primary antibodies: 
nitrotyrosine (1:600, Merck, NJ, USA), fibronectin (1:100, Abcam, Cambridge, UK), 8-OHdG (1:150, 
Bioss Antibodies, MA, USA), Collagen IV (1:100, Abcam, Cambridge, UK) or F4/80 (1:250, Abcam, 
Cambridge, UK) and visualised with the horseradish peroxidase anti-rabbit Envision system (Dako 
Cytochemistry, Tokyo, Japan). Sections were counterstained with haematoxylin and captured for 
analysis. Staining was quantified with ImageJ software (National Institutes of Health, MD, USA).   
Statistical analysis  
Results are expressed as mean ± SD and analysed by one-way ANOVA followed by Fisher’s Least 
Significant (LSD) post hoc tests (GraphPad Prism 7, GraphPad Software, Inc, CA, USA). P<0.05 was 
considered the threshold for statistical significance. 
Results 
Body weight  
Maternal SE and e-vapour replacement during gestation  
At postnatal day (P)1, the body weight of the male offspring from cigarette smoke exposed dams (SE 
group) was smaller than those from Sham exposed dams (11.0 ± 2.6% smaller, P=not significant 
(NS)), and dams with e-vapour replacement from time of conception (Replacement group, P< 0.05 
vs Sham, Table 1). Kidney development, as assessed by kidney weight, was reduced in the SE and 
Replacement groups (17 ± 8.7% and 33 ± 16% lighter than the Sham group, respectively, both P = 
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NS). At P20, both SE and Replacement offspring were significantly smaller than the Sham offspring 
(both P< 0.05, Table 1). However, kidney mass was not different among the 3 groups. At 13 weeks 
(W13), SE offspring remained lighter (P< 0.05 vs Sham), with smaller kidneys both as net weight 
and standardised to body weight as a percentage (both P< 0.05 vs Sham, Table 1). This suggest that 
e-vapour replacement during pregnancy is unlikely to rescue intrauterine growth restriction caused 
by maternal SE. Smoking status prior to pregnancy may also play a key role in foetal development. 
 
Continuous e-vapour exposure during pregnancy  
At P1, offspring from mothers exposed to e-vapour had similar body weight to the Sham offspring, 
regardless of nicotine concentration. However, kidney weights as a percentage of body weight were 
lower in the offspring from dams exposed to nicotine containing e-vapour (E-cig18, 28 ± 10% lower) 
and nicotine-free e-vapour (E-cig0, 36 ± 15% lower) compared to the Sham offspring (both P=NS). 
At P20, E-cig18 offspring were significantly smaller (P< 0.05 vs Sham, Table 2), but E-cig0 offspring 
were significantly larger than the Sham and E-cig18 offspring (P< 0.05 vs Sham and Eicg-18, Table 
2). Kidneys were also heavier in the E-cig0 offspring (P< 0.05 vs Sham, Table 2), which was not 
different from the Sham offspring when standardised by body weight. At W13, maternal e-vapour 
exposure did not affect adult body weight and kidney mass regardless of nicotine concentration. This 
confirms the role of nicotine in foetal underdevelopment; however other chemicals in the e-vapour 
(eg. lipids) may increase early postnatal growth.  
 
Kidney development  
Maternal SE and e-vapour replacement during gestation  
At P1, glomerular number was significantly reduced in SE offspring (P< 0.05 vs Sham, Figure 2a), 
which was not reversed by maternal e-vapour replacement (P< 0.05 Replacement vs Sham, Figure 
2a). At P20, the number of developed glomeruli remained lower in the SE offspring (P< 0.01 vs Sham, 
Figure 2b), which was normalised in the Replacement offspring (P< 0.01 vs SE, Figure2b). At W13, 
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this reduction in glomerular density in the SE group was retained (P< 0.01 vs Sham, Figure 2c), and 
was partially normalised in the Replacement group (P< 0.05 vs SE). In line with reduced glomerular 
number, glomerular perimeter at P20 was increased in the SE offspring (P<0.01 vs Sham), which was 
normalised in the Replacement group (P< 0.01 vs SE, Figure 2d). However, at W13, glomerular 
perimeter was reduced in the SE offspring (P< 0.05 vs Sham, Figure 2e). Urine albumin to creatinine 
ratio was increased in the SE offspring (P< 0.05 vs Sham, Table 1) but not in the Replacement 
offspring compared to the Sham offspring. Although e-vapour replacement is unlikely to rescue 
intrauterine kidney underdevelopment caused by maternal SE prior to gestation, postnatal catch-up 
growth may compensate for glomerular development and function.  
 
Continuous e-vapour exposure during pregnancy  
At P1, glomerular number was lower in the E-cig18 offspring (14 ± 2.9% lower than the Sham 
offspring, P = NS) and the E-cig0 offspring (23 ± 3.6% lower than the Sham offspring, P< 0.05, 
Figure 2a). At P20, E-cig18 and E-cig0 offspring had reduced glomerular density compared to the 
Sham offspring (P< 0.05 and P< 0.01, respectively, Figure 2b). At W13, glomerular density was 
reduced in both the E-cig18 and E-cig0 offspring (P< 0.05 vs Sham, Figure 2c). Glomerular perimeter 
was also significantly reduced in E-cig0 offspring at P20 and 13 W13 (P< 0.05 vs Sham, Figure 2d, 
e). No differences were observed in the urine albumin to creatinine ratio in the W13 offspring between 
the groups (Table 2). Thus, continuous e-vapour exposure adversely affects renal development, which 
is nicotine independent.  
 
Renal oxidative stress and mitochondrial density  
Maternal SE and e-vapour replacement during gestation  
At W13, renal mitochondrial density, reflected by MitoTracker staining, was significantly increased 
in the SE offspring (P< 0.01 vs Sham), which was more than doubled in the Replacement offspring 
(P< 0.01 vs Sham and SE, Figure 3a). Free radical total reactive oxygen species (ROS) level was also 
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doubled in the Replacement group (P< 0.01 vs Sham and SE, Figure 3b), whereas mitochondrial 
specific ROS was only increased in the Replacement group (P< 0.05 vs Sham), but not in the SE 
group (Figure 3c). The expression of a major ROS regulating enzyme, Nox4, was also upregulated in 
the SE group (P< 0.05 vs Sham), but not in the replacement group (Figure 3e). Protein levels of the 
oxidative stress marker, nitrotyrosine, was increased in the SE group (P< 0.01 vs Sham), but was 
reduced in the Replacement group compared to the SE group (P< 0.05, Figure 3f). Furthermore, DNA 
oxidative damage marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) was increased in the SE group 
(P< 0.05 vs Sham) and normalised in the Replacement group (P< 0.05 vs SE, Figure 3g), in line with 
the oxidative stress marker Nox4. This suggests that maternal e-vapour replacement can reduce 
oxidative stress-induced damage caused by maternal SE. 
Continuous e-vapour exposure during pregnancy  
Kidney mitochondrial density was significantly increased in both the E-cig18 and E-cig0 groups (P< 
0.05, P< 0.01 vs Sham, respectively, Figure 3a). ROS level was increased to a similar level in the E-
cig18 and E-cig0 groups (both P< 0.01 vs Sham, Figure 3b). As a result, mitochondrial ROS level 
was also increased in the E-cig18 and E-cig0 groups, respectively (both P< 0.01 vs Sham, Figure 3c). 
Meanwhile, renal Nox4 expression was not significantly different among the three groups (Figure 
3e), suggesting Nox4 is not the major regulator of ROS. Kidney nitrotyrosine expression also 
significantly increased in both the E-cig18 and E-cig0 groups (P< 0.05 vs Sham, Figure 3f), while 8-
OHdg staining was increased only in the E-cig0 group (P< 0.05 vs Sham, Figure 3g). Maternal 
continuous e-vapour exposure increased oxidative stress and related injury in offspring’s kidney, 
which is not nicotine independent. 
 
Inflammatory response and fibrotic change in the kidneys  
Maternal SE and e-vapour replacement during gestation  
At W13, inflammatory marker, MCP-1 expression was upregulated in the SE offspring (P< 0.05 vs 
Sham, Figure 4a), which was normalised in the Replacement offspring. The levels of TNF-α and IL-
12 
 
6 expression was increased in the SE group yet without statistical significance (Figure 4b, c). Renal 
IL-6 expression was however decreased in the Replacement group compared to the SE group (P < 
0.05, Figure 4c). Surface macrophage marker, F4/80, staining was significantly increased in the SE 
group compared to the Sham group at W13 (P< 0.05, Figure 4d). Fibrotic markers, fibronectin and 
collagen IV, were both increased in the kidneys of the SE offspring in adulthood (P< 0.05 vs Sham 
and P< 0.01 vs Sham, Figure 4e, f).  In the Replacement offspring, renal fibronectin expression was 
normalised (P< 0.05 vs SE, Figure 4e); while Collagen IV expression was still increased compared 
to the Sham offspring (P< 0.05, Figure 4f). However, picrosirius red staining did not demonstrate any 
significant changes in mature collagen deposition among the three groups (Figure 4h). Furthermore, 
no significant changes in glomerulosclerosis were observed in PAS stained kidney sections (Figure 
4i).  The overall results suggest that maternal e-vapour replacement can ameliorate maternal SE 
induced inflammatory response and fibrotic changes in the offspring’s kidney. 
 
Continuous e-vapour exposure during pregnancy  
At W13, MCP-1 mRNA expression was nearly doubled in the E-cig18 group only (P<0.05 vs Sham 
and E-cig0, Figure 4a). Renal TNF-α and IL-6 expression were not significantly different among the 
three groups (Figure 4b, c). F4/80, was increased in the kidneys of both the E-cig18 and E-cig0 
offspring compared to the Sham offspring (P< 0.05, Figure 4d). Furthermore, both fibronectin and 
collagen IV staining were increased in the E-cig18 and E-cig0 group compared to the Sham group in 
the kidneys of adult offspring (P< 0.05, Figure 4e, f). However, no changes in picrosirius red staining 
was observed (Figure 4h), indicating no changes in mature collagen deposition. Glomerulosclerosis 
index was also not significantly different among the three treatment groups (Figure 4i). Thus, 





E-cigarettes have emerged as a ‘safe’ replacement to tobacco cigarettes, delivering nicotine with 
fewer and lower levels of other harmful compounds compared to tobacco cigarettes 20. However, 
nicotine is not solely responsible for impairing foetal development by maternal tobacco cigarette 
smoking during pregnancy 2, 20. As such, smoking cessation during gestation is necessary to optimise 
foetal health outcomes. However, quit rates can be as low as 5% 29, even with nicotine replacement 
therapy which is no better than placebo in smoking cessation during pregnancy 11. This makes e-
cigarettes an appealing option as a replacement to tobacco cigarettes, especially with the general 
perception that it is safe during pregnancy. Furthermore, increased usage among the younger 
generation may inadvertently lead to in-utero exposure due to unplanned pregnancies. In this study, 
we found that although replacing tobacco cigarettes with e-cigarettes resulted in increased total ROS 
and mitochondrial specific ROS, overall renal development and function was improved compared to 
continuous cigarette smoke exposure during pregnancy. This beneficial effect was similar to what we 
have observed in brain metabolic markers 23. However, continuous e-vapour exposure during 
pregnancy is still detrimental to foetal development and increased kidney markers of oxidative stress, 
renal inflammation and fibrosis in the adult offspring, independent of nicotine.  
In humans, low birth weight and reduced foetal and infant kidney volumes are commonly observed 
in smokers’ children 30. Kidney underdevelopment is thought to be due to the vasoconstrictive action 
of nicotine which leads to placental insufficiency, limiting intrauterine resources to the kidneys and 
reducing nephron numbers 31. Here, in the SE group, male offspring weighed less after weaning and 
had fewer developed glomeruli, indicating intrauterine growth restriction. This is consistent with our 
previous finding in a different cohort of offspring from SE dams 6, 7, demonstrating the reproducibility 
of this model. At weaning, SE offspring had glomerulomegaly (increased glomerular size) to 
compensate for this reduction in the number of developed glomeruli. However, at adulthood, male 
offspring had fewer developed glomeruli along with a reduction in glomerular size, overall impairing 
renal function as indicated by an increase in the urine albumin to creatinine ratio. This reduction in 
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renal function was associated with an increase in the expression of markers of oxidative stress injury, 
inflammation and fibrosis within the kidneys during adulthood. Similarly, in humans, the progression 
of chronic kidney disease is associated with increased oxidative stress and inflammation, with the 
expression of markers being negatively correlated with kidney function 32-34. Furthermore, 
antioxidant treatments can reduce cigarette smoke induced kidney damage, supporting the critical 
role of oxidative stress in the development of kidney disease 7, 9, 35, 36. 
E-cigarettes have recently emerged as a replacement for tobacco cigarettes, being more popular than 
other forms of nicotine replacement therapy among pregnant women 18. However, their impact on the 
offspring’s health outcomes won’t be fully elucidated by human epidemiological studies for at least 
50 years. As such, animal models can provide perspectives on the future for this birth cohort. In this 
study, birth weight and body weight remained low in the Replacement group compared to the SE 
group likely due to similar levels of nicotine or other chemicals passing the blood-placental barrier 
and reaching the developing foetus. In the Replacement group, intrauterine kidney development was 
not improved since renal profile at birth was similar to the SE offspring. However, glomerular size 
and density were normalised at weaning in the Replacement offspring compared to SE offspring. We 
speculate that this may be due to different chemical components secreted into the breastmilk, allowing 
for catch-up growth during the early postnatal period, which requires further investigation. As a result, 
adult male offspring from the Replacement group did not exhibit a loss of kidney function (as 
indicated by normalised urine albumin to creatinine ratio) even though the markers of oxidative stress 
and fibrosis were increased compared to Sham group, although at lower levels compared to the SE 
group.  
Replacing tobacco cigarettes with e-cigarettes during pregnancy seems to improve renal outcomes in 
the adult male offspring when compared to continuous intrauterine tobacco cigarette smoke exposure. 
However, this needs to be interpreted with caution, as we only adopted a low dose regime for both 
tobacco cigarette smoke and e-vapour exposures. It needs to be noted that this study ended when the 
offspring reached 13 weeks of age, representing young adulthood when mice are just sexually mature. 
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These adverse changes in oxidative stress and fibrotic markers are still of concern even though renal 
function and pathology were not altered at this stage, which is consistent with our previous study 6. 
Since the risk of chronic kidney disease is much higher in the aging population, it remains to be 
determined if these early life changes will increase the risk of developing chronic kidney disease 
given a longer time frame or exposing those offspring to additional postnatal insult, such as smoking 
or consumption of a ‘junk diet’, which are known to deteriorate renal function.  
Even though e-vapour replacement partially restored renal development and function after weaning, 
continuous e-vapour exposure during pregnancy was detrimental to the kidneys of the offspring. 
Although not significant, continuous maternal exposure to nicotine containing e-vapour (E-cig18) 
still affected intrauterine kidney development, with catch-up growth not prominent during the 
suckling period. In addition, increased markers of oxidative stress, inflammation and fibrosis were 
observed in adult offspring’s kidneys, although renal function and pathology appear normal . 
Continuous maternal E-cig0 exposure promoted postnatal growth but simultaneously reduced 
glomerular size and density after weaning, indicating impaired kidney development which persisted 
until adulthood. Furthermore, E-cig0 offspring exhibited increased markers of oxidative stress, 
inflammation and fibrosis compared to Sham offspring. However, these changes were not significant 
enough to cause a loss of renal function at this age.  
Intrauterine e-vapour exposure caused kidney pathological changes in the young adult offspring 
independent of the presence of nicotine, indicating that nicotine is not solely responsible for the 
adverse renal outcomes observed. Previously, maternal exposure to high doses of nicotine increased 
renal fibrosis and reduced glomerular size at P7 and P21 in rats 37. However, the use of nicotine 
patches during pregnancy has not been shown to impact birth weight and intrauterine development in 
humans 38, demonstrating that the observation in the animal study is likely due to unphysiologically 
high dosages. Thus, it is unsurprising that E-cig18 and E-cig0 offspring exhibited similar impairment 
in renal development and increased renal oxidative stress and fibrosis. Other components inside the 
e-vapour could be responsible by damaging mitochondrial wellbeing by increasing mitochondrial 
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ROS level and oxidative stress. In diabetes, oxidative stress and mitochondrial damage have been 
implicated as the key mediators in developing nephropathy 39. Future studies can challenge these 
offspring with diabetes to examine the implication in the development of kidney disease.  
 
Since this is the first study of its kind, there are some limitations. The first is that a low dose of 
cigarette smoke and e-vapour was used, representing the situation of light smokers. Although e-
cigarette replacement improved foetal outcomes compared to continuous tobacco smoke exposure, 
this may not apply to heavy smokers. In addition, since the chemical composition in the e-vapour is 
altered by the heating temperature, using a range of temperature settings can provide more 
comprehensive information.  Furthermore, we only followed up the offspring for 13 weeks, 
representing young adulthood, whereas chronic kidney disease can take decades to develop in humans. 
Therefore, further studies can also investigate the offspring at older ages. 
 
In summary, this study reinforces the notion of adverse renal outcomes caused by maternal cigarette 
smoke exposure during pregnancy. It also provides direct evidence that continuous maternal e-vapour 
exposure throughout pregnancy is also detrimental to offspring’s renal development and induces 
pathological changes independent of nicotine concentration. Although our data shows that the effects 
of maternal e-cigarette exposure are no worse than cigarettes, cessation of either tobacco cigarette 
and/or e-cigarettes should be encouraged during pregnancy to optimise foetal outcomes. 
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Figure 1: Schematic presentation of the study design. SE: cigarette smoke exposure; Replacement: e-
vapour replacing SE during gestation; E-cig18: exposure to nicotine containing e-vapour; E-cig0: 
exposure to nicotine-free e-vapour. 
 Figure 2: Glomerulus histological parameters at 1 day (n = 4), 20 days (n = 5) and 13 weeks (n = 5) 
of age. Results are expressed as mean ± SD. * P< 0.05, ** P< 0.01 vs Sham; # P< 0.05, ## P< 0.01 
vs SE. SE: cigarette smoke exposure; Replacement: e-vapour replacing SE during gestation; E-cig18: 
exposure to nicotine containing e-vapour; E-cig0: exposure to nicotine-free e-vapour.  
Figure 3: Mitochondrial density (a, n = 5), total ROS (b, n = 5), mitochondrial ROS (c, n = 5) and 
markers of oxidative stress Nox4 (g, n=6), nitrotyrosine (f, n = 3) and 8-OHdG (g, n = 3) in W13 
male offspring. Representative images for MitoTracker (green), ROS (red), mitochondrial ROS 
(orange, d) and Nitrotyrosine and 8-OHdG (h) are shown; X40 magnification, scale bar indicates 
50µm and applies to all images. Results are expressed as mean ± SD. * P< 0.05, ** P< 0.01 vs Sham; 
# P< 0.05, vs SE; ‡ P< 0.05 vs E-cig18. SE: cigarette smoke exposure; Replacement: e-vapour 
replacing SE during gestation; E-cig18: exposure to nicotine containing e-vapour; E-cig0: exposure 
to nicotine-free e-vapour.  
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Figure 4: Renal inflammation (MCP-1 (a, n=6), TNF-α (b, n=6), IL-6 (c, n=6), F4/80 (d, n=3)), 
fibrosis (Fibronectin (e, n=3), Collagen IV (f, n=3), Picrosirius Red (g, n=5)) and glomerularsclerosis 
(i, n=5) in W13 male offspring. Representative images for F4/80, fibronectin, collagen IV (g),  
Picrosirius red and Periodic Acid-Schiff are shown (j); X40 magnification, scale bar indicates 50µm 
and applies to all images. Results are expressed as mean ± SD. *P<0.05, **P<0.01 vs Sham; #P<0.05 
vs SE; ‡ P<0.05 vs E-cig18. SE: cigarette smoke exposure; Replacement: e-vapour replacing SE 
during gestation; E-cig18: exposure to nicotine containing e-vapour; E-cig0: exposure to nicotine-
free e-vapour. Table 1: The body and kidney weights of male offspring in Sham, SE and 
Replacement groups at 1 day, 20 days and 13 weeks old.  
 
 
Sham SE Replacement 
P1 n = 18 n = 19 n = 20 
P20 (weaning) n = 12 n = 17 n = 13 
W13 (adulthood)       n = 14 n = 14 n = 16 
    
Body weight (g)    
P1  1.65±0.34 1.47±0.17 1.43±0.22* 
P20  10.45±0.90 9.70±0.91* 9.55±0.50* 
W13  26.78±1.8 25.50±1.1* 25.92±0.96 
Kidney weight (g)    
P1  0.012±0.004 0.010±0.004 0.008±0.003 
P20  0.072±0.010 0.068±0.008 0.074±0.011 
W13  0.22±0.03 0.19±0.04* 0.22±0.04 
Kidney weight (%)    
P1  0.75±0.25 0.60±0.39 0.53±0.22 
P20  0.70±0.07 0.73±0.08 0.77±0.1 
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W13  0.82±0.07 0.78±0.04* 0.87±0.1 
UACR (mg/g)    
W13 (n=6) 2.04±0.80 3.70±1.2* 2.52±0.73 
 
Kidney weights (%) were calculated as a ratio of kidney weight (g) to body weight (g). Results are 
expressed as mean ± SD. *P<0.05 vs Sham. SE: cigarette smoke exposure; Replacement: e-vapour 
replacing SE during gestation; UACR: urine albumin to creatinine ratio. 
Table 2: The body and kidney weights of male offspring in Sham, E-cig18 and E-cig0 groups at 
1 day, 20 days and 13 weeks old. 
 
Sham E-cig18 E-cig0 
P1 n = 18 n = 16 n = 20 
P20 (weaning)           n = 12 n = 15 n = 17 
W13 (adulthood)      n = 14 n = 14 n = 14 
    
Body weight (g)    
P1 1.65±0.34 1.54±0.20 1.60±0.22 
P20 10.45±0.90 9.80±0.43* 11.10±0.78*‡ 
W13 26.78±1.8 26.20±1.0 25.82±1.1 
Kidney weight (g)    
P1 0.012±0.004 0.008±0.002 0.008±0.002 
P20 0.072±0.010 0.071±0.004 0.078±0.004‡ 
W13 0.22±0.03 0.22±0.04 0.22±0.02 
Kidney weight (%)    
P1 0.75±0.25 0.54±0.08 0.49±0.13 
P20 0.70±0.07 0.73±0.04 0.71±0.04 


















Kidney weights (%) were calculated as a ratio of kidney weight (g) to body weight (g). Results are 
expressed as mean ± SD. *P<0.05 vs Sham; ‡ P<0.05 vs E-cig18. E-cig18: exposure to nicotine 
containing e-vapour; E-cig0: exposure to nicotine-free e-vapour; UACR: urine albumin to creatinine 
ratio. 
UACR (mg/g)    
W13 (n=6) 2.04±0.80 1.99±0.69 1.90±0.41 




